LEISHMANIA/MACROPHAGE CELLULAR INTERACTIONS IN VITRO
LEISHMANIA/MACROPHAGE CELLULAR INTERACTIONS IN VITRO
批准号:
2457702
负责人:
Kwang Poo Chang
金额:
$21.94万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 1999-07-31
关键词:
Leishmania major affinity chromatography cell cell interaction cellular pathology electron microscopy glycoproteins glycosylation hamsters host organism interaction intracellular parasitism laboratory mouse laboratory rabbit leishmaniasis macrophage microorganism culture microorganism immunology molecular cloning molecular pathology posttranslational modifications protozoal antigen receptor binding tissue /cell culture transfection virulence
中文摘要
我们的长期目标是阐明利什马尼亚是如何
感染巨噬细胞,以及这些寄生虫随后如何分化,
在这些吞噬细胞中生存和繁殖。了解蜂窝和
体外这种宿主-寄生虫相互作用的分子机制是
对于开发更有效的化学和/或免疫预防和
利什曼病的治疗。
亚马逊利什曼原虫分子以前被认为在
因此建议研究的巨噬细胞感染是:(1)
主要表面糖蛋白/锌蛋白酶(Gp63);和(2)63kb
衣霉素(TM)耐药变异体的染色体外DNA环。更多
重点放在分子方法上。结果表明,L.
并对其进行了克隆和测序。
选择的gp63残基是通过定点突变修饰的
这个物种和另一个物种的基因。Gp63缺陷基因的转染法
带有突变基因的变异体允许在催化和
寄生重要残基。另外两个基因被发现在
野生型基因转染后63kb DNA环的功能分析
带有这种DNA的缺失克隆的细胞。其中一人被发现授予
衣霉素耐药,明显编码N-乙酰氨基葡萄糖-1-
磷酸转移酶(NAGTase)。利用该基因作为选择性标记,
另一个直接位于上游的基因被鉴定出来,并发现过度表达
一个36kd的蛋白质,与Zeta-晶体蛋白/NADPH对苯二酚同源
氧化还原酶(P36)。
提议继续上述工作,同时与
已建立的体外转染法和巨噬细胞感染系统
如下:(1)优化功能基因的转染率
分析gp63和其他相关分子;(2)进一步分析
催化、受体结合等功能的生物学重要性
利什曼病感染中gp63基序的研究:(3)进一步研究利什曼病
翻译后修饰语在调节中的功能意义
利用N-糖基化和GPI锚定突变体表达gp63;
试图通过负性和负性来识别额外的相关分子
阳性表型选择;(5)描述“无毒”的前鞭毛体-
作为细胞内缺陷突变体的衍生无性无鞭毛体
分化和/或复制。
这些拟议研究的结果将不仅有助于我们理解
利什曼原虫分子在其感染巨噬细胞时也具有可比性
其他生物系统中的分子。
英文摘要
Our long term objectives are to elucidate the questions of how Leishmania
infect macrophages, and how these parasites subsequently differentiate,
survive and multiply in these phagocytes. Understanding the cellular and
molecular mechanisms of such host-parasite interactions in vitro is
crucial for developing more effective chemo- and/or immuno-prophylaxis and
therapy for leishmaniasis.
Leishmania amazonensis molecules previously thought to be important in
macrophage infection and thus proposed for investigation are: (1) the
major surface glycoprotein/zinc proteinase (gp63); and (2) the 63 kb
extrachromosomal DNA circles in tunicamycin (TM)-resistant variants. More
emphasis has been placed on the molecular approaches. The gp63 gene of L.
amazonensis was cloned and sequenced.
Selected residues of gp63 were modified by site-specific mutagenesis of
the genes from this and another species. Transfection of gp63-deficient
variants with mutant genes allows the identification of catalytically and
parasitically important residues. Two additional genes were identified in
the 63 kb DNA circle by functional analysis after transfection of wildtype
cells with deletion clones of this DNA. One was found to confer
tunicamycin-resistance, apparently encoding N-acetylglucosamine-1-
phosphate transferase (NAGTase). Using this gene as a selective marker,
another gene immediately upstream was identified and found to overexpress
a 36 kd protein, homologous to zeta-crystallin/NADPH quinone
oxidoreductase (P36).
It is proposed to continue the above-mentioned work in conjunction with
the established in vitro transfection and macrophage infection systems as
follows: (1) To optimize the efficiency of transfection for functional
analysis of gp63 and other relevant molecules; (2) To further analyze the
biological importance of catalytic, receptor-binding and other functional
motifs of gp63 in leishmanial infection; (3) To further characterize the
functional significance of posttranslational modifications in regulating
gp63 expression by using N-glycosylation and GPI-anchor mutants; (4)
Attempts to identify additional molecules of relevance by negative and
positive phenotype selections; (5) To delineate "avirulent" promastigote-
derived axenic amastigotes as mutants defective in intracellular
differentiation and/or replication.
The results of these proposed studies will help our understanding not only
Leishmania molecules in their infection of macrophages but also comparable
molecules in other biological systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Photo-inactivation of Leishmania for safe and effective delivery of surrogate vac
-
批准号:8514509
-
项目类别:
-
资助金额:$18.15万
-
财政年份:2012
-
负责人:Kwang Poo Chang
-
依托单位:
Photo-inactivation of Leishmania for safe and effective delivery of surrogate vac
-
批准号:8386400
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2012
-
负责人:Kwang Poo Chang
-
依托单位:
Toward suicidal automation of porphyric Leishmania for photodynamic vaccination
-
批准号:7914385
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:Kwang Poo Chang
-
依托单位:
Toward suicidal automation of porphyric Leishmania for photodynamic vaccination
-
批准号:7712375
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:Kwang Poo Chang
-
依托单位:
Transgenic porphyric Leishmania as suicidal live vaccines against leishmaniasis
-
批准号:7078078
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2006
-
负责人:Kwang Poo Chang
-
依托单位:
Transgenic porphyric Leishmania as suicidal live vaccines against leishmaniasis
-
批准号:7230091
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2006
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130194
-
项目类别:
-
资助金额:$22.71万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130195
-
项目类别:
-
资助金额:$23.62万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130188
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
Leishmania-macrophage cellular interactions in vitro
-
批准号:6843802
-
项目类别:
-
资助金额:$27.3万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130192
-
项目类别:
-
资助金额:$17.35万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:2061236
-
项目类别:
-
资助金额:$23.33万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130189
-
项目类别:
-
资助金额:$21.43万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
Leishmania-macrophage cellular interactions in vitro
-
批准号:6439869
-
项目类别:
-
资助金额:$27.3万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130191
-
项目类别:
-
资助金额:$23.73万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130190
-
项目类别:
-
资助金额:$23.34万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA/MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:2061237
-
项目类别:
-
资助金额:$24.09万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA/MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:2061239
-
项目类别:
-
资助金额:$21.09万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA/MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:2671774
-
项目类别:
-
资助金额:$22.81万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
LEISHMANIA-MACROPHAGE CELLULAR INTERACTIONS IN VITRO
-
批准号:3130193
-
项目类别:
-
资助金额:$21.84万
-
财政年份:1983
-
负责人:Kwang Poo Chang
-
依托单位:
海外基金